Comparative bioavailability of isoniazid, rifampicin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. - Acocella,G.; Nonis,A.; Perna,G.; Patane,E.; Gildroni-Grassi,G.; Grassi,C. (Am Rev Respir Dis, 1988)